Prostate cancer cases have increased in recent years, increasing 3% per year since 2014, and now former President Joe Biden is one of the more than 300,000 men who are diagnosed this year.
The Biden office published the announcement on Sunday, days after the news that a “small nodule” had been found in the prostate of the former president who carried out a routine exam.
“While this represents a more aggressive form of the disease, cancer seems to be sensitive to hormones, allowing effective management,” said his office. “The president and his family are reviewing the treatment options with their doctors.”
The new prostate cancer test indicates the disease better than the PSA option, the study finds
The treatment is usually more effective when prostate cancer is sensitive to hormones, since that means that the disease will probably respond better to hormonal therapy, according to the Mayo Clinic.
Hormonal therapy is used to block the effects of hormones that feed the growth of prostate cancer cells.

Former President Joe Biden is one of the more than 300,000 people who are diagnosed with prostate cancer this year. (Getty images)
“Prostate cancer cells depend on testosterone to help them grow. Cutting the testosterone supply can cause cancer cells to die or grow more slowly,” said the previous source.
In addition to hormonal therapy, common treatment options for prostate cancer include chemotherapy, directed therapy, immunotherapy and treatments with armaceutical radio.
What to know about prostate cancer
Prostate cancer It is a disease found in men that develops in the prostate gland.
Around 313,780 new cases of prostate cancer will be diagnosed in 2025, and 35,770 men who of the disease, according to the American cancer society.
Hormonal therapy is used to block the effects of hormones that feed the growth of prostate cancer cells.
One in eight men will be diagnosed with prostate cancer in his life, he declared the same source.
Older men have a high risk of disease, with six out of 10 cases diagnosed in patients with 65 years or more. The average age in the diagnosis is 67, with men under 40 rarely affected. Biden has 82.
Prostate cancer medication now available for more patients with an aggressive manner
Prostate cancer is the second most common cancer in men, just behind Skin cancerACS pointed out.
Signs and symptoms
Among men who undergo routine prostate cancer detection, the disease is commonly trapped before symptoms arise, according to ACS.
Typical early symptoms include urinating problems, a weak or slow urinary current or a greater need to urinate.

Around 313,780 new cases of prostate cancer will be diagnosed in 2025 and 35,770 men will do it of the disease, according to the American Cancer Society. (Istock)
Some men may also notice blood in the urine or body fluids.
More advanced symptoms can occur after the disease has spread. Those may include hips pain, back (column), chest (ribs) or other areas, according to ACS.
Click here to get the Fox News application
Men can also suffer erectile dysfunction, weight loss, extreme fatigue, weakness in the legs or feet, or loss or control of leaf or intestine.
Detection recommendations
The US Preventive Services Task Force. UU. It states that men aged 55 to 69 must undergo the option of undergoing periodic detection based on prostate antigen (PSA) for prostate cancer.
“Before deciding whether to be evaluated, men should have the opportunity to discuss the possible benefits and damage of detection with their clinician and incorporate their values and preferences in the decision,” says the USPSTF.

While detection sacrifices a “small potential benefit” to reduce the possibilities of dying of the disease, health officials warn that some men may experience negative effects. (Istock)
While detection sacrifices a “small potential benefit” to reduce the possibilities of dying of the disease, the agency said that some men may experience negative effects, including false positives, overdiagnosis and overload and treatment complications.
Currently, alternative prostate cancer detection methods are being investigated, including one that uses a non -invasive urine test, as Fox News Digital recently reported.
Survival rates
For localized prostate cans, where the disease is contained within the prostate, the five -year survival rate is at least 99%, according to the ACS.
Click here to register in our health newsletter
For regional cases, where the disease has extended only to “nearby structures or lymph nodes”, the five -year survival rate is also 99% or more.
For more health articles, visit www.foxnews.com/health
If cancer has spread to other areas of the body, the five -year survival rate decreases to 37%.
Royal survival rates may vary according to the patient’s age, general health, how cancer has progressed after diagnosis, the response of the disease to treatment and other factors, ACS said.